ROBERT ATMAR to Influenza B virus
This is a "connection" page, showing publications ROBERT ATMAR has written about Influenza B virus.
Connection Strength
0.712
-
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial. Vaccine. 2023 04 17; 41(16):2716-2722.
Score: 0.208
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season. MMWR Recomm Rep. 2020 08 21; 69(8):1-24.
Score: 0.174
-
Typing and subtyping clinical isolates of influenza virus using reverse transcription-polymerase chain reaction. Clin Diagn Virol. 1996 Nov; 7(2):77-84.
Score: 0.133
-
Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis. 2006 Mar 15; 193(6):760-4.
Score: 0.063
-
Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol. 2002 Nov; 40(11):4353-6.
Score: 0.051
-
Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens. J Clin Microbiol. 2000 Mar; 38(3):1161-5.
Score: 0.042
-
Host Transcriptional Response to Influenza and Other Acute Respiratory Viral Infections--A Prospective Cohort Study. PLoS Pathog. 2015 Jun; 11(6):e1004869.
Score: 0.030
-
Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 1999 Oct 28; 341(18):1336-43.
Score: 0.010